Rizzo V - Search Results

1

Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs.

Innao V, Rizzo V, Allegra AG, Musolino C, Allegra A. Innao V, et al. Among authors: rizzo v. Curr Oncol. 2020 Dec 25;28(1):159-183. doi: 10.3390/curroncol28010019. Curr Oncol. 2020. PMID: 33704184 Free PMC article. Review.

2

Myeloproliferative Disease: Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera.

Musolino C, Alonci A, Bellomo G, Tringali O, Spatari G, Quartarone C, Rizzo V, Calabrò L, Bagnato G, Frisina N. Musolino C, et al. Among authors: rizzo v. Hematology. 2000;4(5):397-402. Hematology. 2000. PMID: 11399581

3

Soluble angiogenic factors: implications for chronic myeloproliferative disorders.

Musolino C, Calabro' L, Bellomo G, Martello F, Loteta B, Pezzano C, Rizzo V, Alonci A. Musolino C, et al. Among authors: rizzo v. Am J Hematol. 2002 Mar;69(3):159-63. doi: 10.1002/ajh.10020. Am J Hematol. 2002. PMID: 11891801 Free article.

4

[Lipid profile in hematologic neoplasms].

Musolino C, Calabrò L, Bellomo G, Cincotta M, Di Giacomo V, Pezzano C, Loteta B, Rizzo V, Guglielmo S, Alonci A. Musolino C, et al. Among authors: rizzo v. Recenti Prog Med. 2002 May;93(5):298-301. Recenti Prog Med. 2002. PMID: 12050911 Italian.

5

Nanoparticles in oncology: the new theragnostic molecules.

Allegra A, Penna G, Alonci A, Rizzo V, Russo S, Musolino C. Allegra A, et al. Among authors: rizzo v. Anticancer Agents Med Chem. 2011 Sep;11(7):669-86. doi: 10.2174/187152011796817682. Anticancer Agents Med Chem. 2011. PMID: 21787275 Review.

6

Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera.

Musolino C, Alonci A, Bellomo G, Tringali O, Spatari G, Quartarone C, Rizzo V, Calabrò L, Bagnato G, Frisina N. Musolino C, et al. Among authors: rizzo v. Hematology. 1999;4(5):397-402. doi: 10.1080/10245332.1999.11746464. Hematology. 1999. PMID: 27426843

7

Promising Anti-Mitochondrial Agents for Overcoming Acquired Drug Resistance in Multiple Myeloma.

Innao V, Rizzo V, Allegra AG, Musolino C, Allegra A. Innao V, et al. Among authors: rizzo v. Cells. 2021 Feb 19;10(2):439. doi: 10.3390/cells10020439. Cells. 2021. PMID: 33669515 Free PMC article. Review.

8

Genetic Heterogeneity in Chronic Myeloid Leukemia: How Clonal Hematopoiesis and Clonal Evolution May Influence Prognosis, Treatment Outcome, and Risk of Cardiovascular Events.

Sant'Antonio E, Camerini C, Rizzo V, Musolino C, Allegra A. Sant'Antonio E, et al. Among authors: rizzo v. Clin Lymphoma Myeloma Leuk. 2021 Sep;21(9):573-579. doi: 10.1016/j.clml.2021.04.014. Epub 2021 Apr 29. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34078586 Review.

9

Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma.

Allegra A, Rizzo V, Innao V, Alibrandi A, Mazzeo A, Leanza R, Terranova C, Gentile L, Girlanda P, Allegra AG, Alonci A, Musolino C. Allegra A, et al. Among authors: rizzo v. Arch Med Sci. 2021 Jan 11;18(3):696-703. doi: 10.5114/aoms/114269. eCollection 2022. Arch Med Sci. 2021. PMID: 35591819 Free PMC article.

10

[Hypersplenism: current status and perspectives].

Musolino C, Calabrò L, Alonci A, Quartarone C, Bellomo G, Neri S, Rizzo V, Pernice F, Frisina N. Musolino C, et al. Among authors: rizzo v. Recenti Prog Med. 1999 Sep;90(9):488-94. Recenti Prog Med. 1999. PMID: 10544672 Review. Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

532 results

Search Page